The Key Players in Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019.

Monday 10 August 2015, Amsterdam

The report recognizes the following companies as the key players in the Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market: R & D Systems (a Biotechne brand), Thermofisher Scientific (brand: Life Technology), ZEUS Scientific.

Other Prominent Vendors in the market are Abbexa, Abcam, Abelisa, Abnova, Active Motif, Affinity Biologicals, Affymetrix, Agdia Biofords, ALPCO, AMS Biotechnology, ANIARA, Beckman Coulter, Bhat Bio-tech, Bio-Rad Laboratories, Biorbyt, Biosensis, BioVision, Boster Bio, Calbiotech, Cayman Chemicals,Cell Sciences, Creative Diagnostic, Crystal Chem, Cygnus Technologies, Dako, Diaclone, Diagenics, Eagle Biosciences, Euro Diagnostica, Genasia, Genway Biotech, Gold Standard Diagnostics, Helica BioSystems, Hycult Biotech, IBL America, Immuno Laboratories, IVD Technologies, JEI DANIEL BIOTECH, KOMABIOTECH, Labor Diagnostika Nord, Life Diagnostics, Lifespan Biosciences, MitoSciences, MOLECULAR INNOVATION, Monobind, NEOGEN, Neurotune, Omega Diagnostics, Oranoxis, PeproTech, Pribolab, QIAGEN, Quidel, Randox Life Sciences, RayBiotech, Rockland Immunochemicals, Stellar Biotechnologies, United States Biological, Vector Laboratories, x-OvO.

Commenting on the report, an analyst said, “One major trend in this market is development of automated immunoassays. Automation of immunoassays is not a new concept, but innovation in automation leads to the development of advanced and efficient systems. Automation affects the procedural workflow by decreasing the operation time and increasing the productivity of immunoassays. ”

According to the report, one key driver of this market is high prevalence of chronic diseases. Aging, unhealthy dietary habits, hereditary disorders, lack of exercise, and increased consumption of alcohol are some factors leading to an increased incidence of chronic diseases in individuals.

Further, the report states that one of the major challenges is the Threat from low-cost products. The knowledge of the most advanced ELISA products is limited among researchers and medical personnel because of the frequent launch of new technologies in the market. Vendors in the market compete based on the cost and design of ELISA products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019

Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019

Publish date : August 2015
Report code : ASDR-212484
Pages : 55 Media contact: S. Koopman - Marketing and Communications / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E :

 back to News